Colorectal cancer

Cetuximab

Off

NICE appraisal

(August 2009)

DSU reports

Cetuximab for the first line treatment of metastatic colorectal cancer: Addendum (PDF, 11KB) (May 2009)

Cetuximab for the first line treatment of metastatic colorectal cancer (PDF, 99KB) (March 2009)

Related information

Appraisal specific projects

A global reputation

91Ö±²¥ is a world top-100 research university with a global reputation for excellence. We're a member of the Russell Group: one of the 24 leading UK universities for research and teaching.

91Ö±²¥ the University